This study aimed to investigate the clinical significance of changes in interleukin-18 (IL-18) and neutrophil/lymphocyte ratio (NLR) in the pathogenesis of AAV and the impact of NLR on the prognosis of patients. This evidence concerns the gene IL18 and anti-neutrophil cytoplasmic antibody-associated vasculitis.